Eton Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	19.66	25.94	14.94	21.39	16.31	14.41
Cash & Short-Term Investments	19.66	25.94	14.94	21.39	16.31	14.41
Cash Growth	12.86%	73.69%	-30.17%	31.17%	13.18%	-32.35%
Accounts Receivable	13.41	11.76	5.36	3.41	1.85	5.47
Inventory	14.47	15.42	15.23	0.91	0.56	0.55
Other Current Assets	5.71	7.46	5.49	1.13	1.29	3.18
Total Current Assets	53.25	60.58	41.02	26.84	20	23.6
Net Property, Plant & Equipment	0.67	0.64	0.21	0.15	0.26	0.22
Other Intangible Assets	43.74	30.88	34.88	4.74	4.75	3.62
Other Long-Term Assets	0.05	0.02	0.01	0.01	0.01	0.02
Total Assets	97.71	92.11	76.12	31.74	25.03	27.47
Accounts Payable	13.49	10.98	4.17	1.85	1.77	1.77
Accrued Expenses	18.89	18.73	15.78	9.01	3.66	1.37
Short-Term Debt	11.81	8.79	-	-	-	-
Current Portion of Long-Term Debt	-	-	-	5.38	1.03	1.42
Total Current Liabilities	44.18	38.49	19.95	16.24	6.46	4.56
Long-Term Debt	18.94	21.77	29.81	-	5.38	5.26
Long-Term Leases	0.44	0.46	0.11	0.02	0.11	0.02
Other Long-Term Liabilities	3.54	5.24	1.83	-	-	-
Total Long-Term Liabilities	22.92	27.47	31.75	0.02	5.49	5.28
Total Liabilities	67.1	65.96	51.7	16.26	11.95	9.84
Common Stock	0.03	0.03	0.03	0.03	0.03	0.03
Additional Paid-in Capital	141.53	138.62	132.29	119.52	116.19	111.72
Retained Earnings	-110.94	-112.49	-107.89	-104.07	-103.13	-94.11
Shareholders' Equity	30.62	26.15	24.43	15.48	13.08	17.63
Total Liabilities & Equity	97.71	92.11	76.12	31.74	25.03	27.47
Total Debt	31.19	31.02	29.92	5.4	6.52	6.7
Net Cash (Debt)	-11.53	-5.08	-14.98	15.99	9.78	7.71
Net Cash Growth	-	-	-	63.44%	26.85%	-45.52%
Net Cash Per Share	-0.40	-0.19	-0.58	0.62	0.39	0.31
Book Value	30.62	26.15	24.43	15.48	13.08	17.63
Book Value Per Share	1.05	0.97	0.94	0.60	0.52	0.70
Tangible Book Value	-13.12	-4.72	-10.45	10.74	8.32	14.01
Tangible Book Value Per Share	-0.45	-0.18	-0.40	0.42	0.33	0.56

SEC Filings: 10-K · 10-Q